Vikrant Minhas
Vikrant Minhas
Verified email at
Cited by
Cited by
Capacity to utilize raffinose dictates pneumococcal disease phenotype
V Minhas, RM Harvey, LJ McAllister, T Seemann, AE Syme, SL Baines, ...
MBio 10 (1), e02596-18, 2019
In vivo dual RNA-seq reveals that neutrophil recruitment underlies differential tissue tropism of Streptococcus pneumoniae
V Minhas, R Aprianto, LJ McAllister, H Wang, SC David, KT McLean, ...
Communications biology 3 (1), 1-12, 2020
Enhanced safety and immunogenicity of a pneumococcal surface antigen A mutant whole‐cell inactivated pneumococcal vaccine
SC David, Z Laan, V Minhas, AY Chen, J Davies, TR Hirst, SR McColl, ...
Immunology and cell biology 97 (8), 726-739, 2019
Host-glycan metabolism is regulated by a species-conserved two-component system in Streptococcus pneumoniae
PR Andreassen, C Trappetti, V Minhas, FD Nielsen, K Pakula, JC Paton, ...
PLoS pathogens 16 (3), e1008332, 2020
Site-specific mutations of GalR affect galactose metabolism in Streptococcus pneumoniae
KT McLean, A Tikhomirova, EB Brazel, S Legendre, G Haasbroek, ...
Journal of Bacteriology 203 (1), e00180-20, 2020
Sickly Sweet–How Sugar Utilization Impacts Pneumococcal Disease Progression
V Minhas, JC Paton, C Trappetti
Trends in Microbiology, 2021
Pathogenesis of Streptococcus pneumoniae-a molecular characterisation
V Minhas
The system can't perform the operation now. Try again later.
Articles 1–7